Evidence map›Paper›PMID 38388885›Full record

ReviewBMC ophthalmology2024

Goldenhar syndrome with limbal neoformation, microtia and skeletal deformities: a case report and literature review.

Yushan Fu, Haotian Yu, Jiajia Zhang, Nan Zhou

Open access · goldAbstract readReviewCase Reports
In one paragraph

Review in BMC ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yushan FuDepartment of Ophthalmology, the Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
Haotian YuDepartment of Ophthalmology, the Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
Jiajia ZhangDepartment of Ophthalmology, the Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China.
Nan ZhouDepartment of Ophthalmology, the Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, China. nzhou_hmu@126.com.
Second Affiliated Hospital of Harbin Medical University · CNHarbin Medical University · CN

Funding

Natural Science Foundation of Heilongjiang Province of China LH2023H041
6 · The paper itself

Abstract

backgroundTo report a case of a 4-year-old patient with Goldenhar syndrome. CASE PRESENTATION: The author presents a rare case report involving a 4-year-old boy with multiple malformations. A comprehensive examination showed that the patient primarily had a limbal dermoid. He also has bilateral microtia and ear canal deformities. The skull CT scan and spine X-ray showed Maxillofacial Abnormalities and scoliosis. Whole Exome Sequencing revealed potential gene variations related to microtia. Although certain circumstances prevented us from initiating follow-up treatment for the patient, we have provided a detailed account of the diagnostic methodologies used for this condition.

conclusionsGoldenhar syndrome is a congenital condition, predominantly presenting as sporadic cases. Its diagnosis and management typically necessitate the involvement of multiple disciplines, including otolaryngology and craniofacial surgery. The syndrome encompasses a variety of craniofacial features, which can facilitate early diagnosis and guide subsequent therapeutic interventions.

Indexed as

Abnormalities, MultipleCongenital MicrotiaEye NeoplasmsGoldenhar SyndromeChild, PreschoolHumansMaleTomography, X-Ray ComputedEpibulbar dermoidGoldenhar syndromeHemifacial microsomiaMandibular hypoplasia

Identifiers

PMID38388885
PMCPMC10882892
OpenAlexW4392057610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.